论文部分内容阅读
目的:分析人类乳头状病毒(HPV)检测诊断宫颈癌前病变的临床价值,为宫颈癌的临床诊断提供参考。方法:将该院2013年5月至2015年10月经防癌普查收治的90例宫颈病变患者分别用传统宫颈细胞学TCT及人类乳头状病毒检测,以病理学诊断为金标准,对两种方式的特异性及敏感性进行比较和分析。结果:采用人类乳头状病毒检测的特异度及灵敏度分别为93.4%及93.1%;采用传统宫颈细胞学诊断的特异性及敏感性分别为80.3%及72.4%;组间比较具有统计学意义(P<0.05)。结论:相比传统细胞学检查,人类乳头状病毒检测诊断宫颈癌前病变的特异性及敏感性较高,值得推广。
Objective: To analyze the clinical value of human papillomavirus (HPV) in diagnosing cervical precancerous lesions and provide reference for the clinical diagnosis of cervical cancer. Methods: Ninety patients with cervical lesions treated by anti-cancer screening from May 2013 to October 2015 in our hospital were detected by traditional cervical cytology (TCT) and human papillomavirus (HPV) respectively. The pathological diagnosis was used as the gold standard. The specificity and sensitivity were compared and analyzed. Results: The specificity and sensitivity of human papillomavirus (HPV) were 93.4% and 93.1%, respectively. The specificity and sensitivity of traditional cervical cytology were 80.3% and 72.4%, respectively. The differences between the two groups were statistically significant (P <0.05). CONCLUSION: Compared with traditional cytology, human papillomavirus (HPV) detection is more specific and sensitive in diagnosing cervical precancerous lesions and is worth promoting.